Murray Stahl's LLY Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 4,247 shares of Eli Lilly and Company (LLY) worth $3.24 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in LLY, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2023, adding 5,437 shares. Largest reduction occurred in Q1 2023, reducing 6,886 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +35,961 | Add 0.00% | 35,960 | $49.14 |
| Q4 2013 | -5,300 | Reduce 14.74% | 30,660 | $51.01 |
| Q1 2014 | +137 | Add 0.45% | 30,797 | $58.87 |
| Q2 2014 | -350 | Reduce 1.14% | 30,447 | $62.17 |
| Q4 2014 | +30 | Add 0.10% | 30,477 | $69.00 |
| Q1 2015 | -30 | Reduce 0.10% | 30,447 | $72.65 |
| Q1 2016 | -378 | Reduce 1.24% | 30,069 | $72.00 |
| Q3 2016 | -1,453 | Reduce 4.83% | 28,616 | $80.27 |
| Q4 2016 | -2,000 | Reduce 6.99% | 26,616 | $73.56 |
| Q1 2017 | -1,525 | Reduce 5.73% | 25,091 | $84.09 |
| Q2 2017 | +356 | Add 1.42% | 25,447 | $82.33 |
| Q3 2017 | -365 | Reduce 1.43% | 25,082 | $85.52 |
| Q1 2018 | -1,000 | Reduce 3.99% | 24,082 | $77.40 |
| Q2 2018 | -1,500 | Reduce 6.23% | 22,582 | $85.33 |
| Q3 2018 | -1,328 | Reduce 5.88% | 21,254 | $107.27 |
| Q4 2018 | -2,000 | Reduce 9.41% | 19,254 | $115.72 |
| Q1 2019 | +17,255 | Add 0.00% | 17,254 | $129.77 |
| Q2 2019 | -4,100 | Reduce 23.76% | 13,154 | $110.76 |
| Q3 2020 | -1,000 | Reduce 7.60% | 12,154 | $148.02 |
| Q4 2020 | -1,000 | Reduce 8.23% | 11,154 | $168.82 |
| Q1 2021 | -2,768 | Reduce 24.82% | 8,386 | $186.86 |
| Q4 2021 | -1,000 | Reduce 11.92% | 7,386 | $276.20 |
| Q4 2022 | -500 | Reduce 6.77% | 6,886 | $365.84 |
| Q1 2023 | -6,886 | Sold Out | 0 | $0.00 |
| Q2 2023 | +5,437 | New Buy | 5,437 | $468.98 |
| Q3 2023 | -260 | Reduce 4.78% | 5,177 | $537.13 |
| Q4 2023 | -422 | Reduce 8.15% | 4,755 | $582.92 |
| Q1 2024 | +2 | Add 0.04% | 4,757 | $777.96 |
| Q2 2024 | -500 | Reduce 10.51% | 4,257 | $905.38 |
| Q3 2024 | -141 | Reduce 3.31% | 4,116 | $885.94 |
| Q4 2024 | +141 | Add 3.43% | 4,257 | $772.00 |
| Q2 2025 | -151 | Reduce 3.55% | 4,106 | $779.53 |
| Q3 2025 | +141 | Add 3.43% | 4,247 | $763.00 |
Murray Stahl's Eli Lilly and Company Investment FAQs
Murray Stahl first purchased Eli Lilly and Company (LLY) in Q2 2013, acquiring 35,960 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Eli Lilly and Company (LLY) for 50 quarters since Q2 2013.
Murray Stahl's largest addition to Eli Lilly and Company (LLY) was in Q2 2013, adding 35,960 shares worth $1.77 M.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 4,247 shares of Eli Lilly and Company (LLY), valued at approximately $3.24 M.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.04% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Eli Lilly and Company (LLY) was 35,960 shares, as reported at the end of Q2 2013.